DK1141308T3 - Gruppe B streptococcus proteiner og deres anvendelse - Google Patents

Gruppe B streptococcus proteiner og deres anvendelse

Info

Publication number
DK1141308T3
DK1141308T3 DK99962422T DK99962422T DK1141308T3 DK 1141308 T3 DK1141308 T3 DK 1141308T3 DK 99962422 T DK99962422 T DK 99962422T DK 99962422 T DK99962422 T DK 99962422T DK 1141308 T3 DK1141308 T3 DK 1141308T3
Authority
DK
Denmark
Prior art keywords
group
streptococcus proteins
streptococcus
proteins
Prior art date
Application number
DK99962422T
Other languages
Danish (da)
English (en)
Inventor
Martin John Glenton Hughes
J D C O Santangelo
Jonathan Douglas Lane
Paul Everest
Robert Feldman
Joanne Christine Moore
Rebecca Kerry Wilson
Richard James Dobson
Gordon Dougan
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9828359.1A external-priority patent/GB9828359D0/en
Priority claimed from GBGB9828356.7A external-priority patent/GB9828356D0/en
Priority claimed from GBGB9828353.4A external-priority patent/GB9828353D0/en
Priority claimed from GBGB9828357.5A external-priority patent/GB9828357D0/en
Priority claimed from GBGB9828350.0A external-priority patent/GB9828350D0/en
Priority claimed from GBGB9828355.9A external-priority patent/GB9828355D0/en
Priority claimed from GBGB9828349.2A external-priority patent/GB9828349D0/en
Priority claimed from GBGB9828352.6A external-priority patent/GB9828352D0/en
Priority claimed from GBGB9828354.2A external-priority patent/GB9828354D0/en
Priority claimed from GBGB9828345.0A external-priority patent/GB9828345D0/en
Priority claimed from GBGB9900083.8A external-priority patent/GB9900083D0/en
Priority claimed from GBGB9900082.0A external-priority patent/GB9900082D0/en
Priority claimed from GBGB9900085.3A external-priority patent/GB9900085D0/en
Priority claimed from GBGB9900084.6A external-priority patent/GB9900084D0/en
Priority claimed from GBGB9900086.1A external-priority patent/GB9900086D0/en
Priority claimed from GBGB9901922.6A external-priority patent/GB9901922D0/en
Priority claimed from GBGB9901916.8A external-priority patent/GB9901916D0/en
Application filed by Microscience Ltd filed Critical Microscience Ltd
Application granted granted Critical
Publication of DK1141308T3 publication Critical patent/DK1141308T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
DK99962422T 1998-12-22 1999-12-22 Gruppe B streptococcus proteiner og deres anvendelse DK1141308T3 (da)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
GBGB9828357.5A GB9828357D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828350.0A GB9828350D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828355.9A GB9828355D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828349.2A GB9828349D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828356.7A GB9828356D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828353.4A GB9828353D0 (en) 1998-12-22 1998-12-22 Protein and compositions containig it
GBGB9828352.6A GB9828352D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828359.1A GB9828359D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828345.0A GB9828345D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828354.2A GB9828354D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9900082.0A GB9900082D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900085.3A GB9900085D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900084.6A GB9900084D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900086.1A GB9900086D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900083.8A GB9900083D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9901916.8A GB9901916D0 (en) 1999-01-28 1999-01-28 Protein and compositions containing it
GBGB9901922.6A GB9901922D0 (en) 1999-01-28 1999-01-28 Protein and compositions containing it
PCT/GB1999/004377 WO2000037646A2 (en) 1998-12-22 1999-12-22 Group b streptococcus proteins, and their use

Publications (1)

Publication Number Publication Date
DK1141308T3 true DK1141308T3 (da) 2007-06-04

Family

ID=27585888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99962422T DK1141308T3 (da) 1998-12-22 1999-12-22 Gruppe B streptococcus proteiner og deres anvendelse

Country Status (23)

Country Link
US (3) US6812021B1 (cs)
EP (3) EP1757696A3 (cs)
JP (1) JP2002533083A (cs)
KR (3) KR100790653B1 (cs)
CN (1) CN101066447A (cs)
AP (1) AP1502A (cs)
AT (1) ATE353367T1 (cs)
AU (1) AU776735B2 (cs)
CA (1) CA2354135A1 (cs)
CY (1) CY1106559T1 (cs)
CZ (1) CZ20012172A3 (cs)
DK (1) DK1141308T3 (cs)
EA (1) EA004444B1 (cs)
ES (1) ES2281977T3 (cs)
HK (1) HK1039353A1 (cs)
HU (1) HUP0104825A3 (cs)
NO (1) NO20013102L (cs)
NZ (3) NZ512297A (cs)
OA (1) OA11734A (cs)
PL (1) PL201887B1 (cs)
PT (1) PT1141308E (cs)
SI (1) SI1141308T1 (cs)
WO (1) WO2000037646A2 (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1733800A (zh) * 1998-12-22 2006-02-15 微科学有限公司 外表面蛋白质及其基因和用途
DK1141308T3 (da) * 1998-12-22 2007-06-04 Microscience Ltd Gruppe B streptococcus proteiner og deres anvendelse
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
GB0105922D0 (en) * 2001-03-09 2001-04-25 Microscience Ltd Genes and proteins, and their use
US6849407B2 (en) 2000-08-31 2005-02-01 Mayo Foundation For Medical Education And Research Detection of varicella-zoster virus
GB0021977D0 (en) 2000-09-07 2000-10-25 Pyrosequencing Ab Method of sequencing DNA
US7691571B2 (en) 2001-01-31 2010-04-06 Mayo Foundation For Medical Education And Research Detection of bordetella
US7074598B2 (en) 2002-09-25 2006-07-11 Mayo Foundation For Medical Education And Research Detection of vancomycin-resistant enterococcus spp.
US7365176B2 (en) 2002-09-26 2008-04-29 Mayo Foundation For Medical Education And Research Detection of Epstein-Barr virus
WO2004050846A2 (en) * 2002-12-02 2004-06-17 Biosynexus Incorporated Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
US7427475B2 (en) 2003-11-18 2008-09-23 Mayo Foundation For Medical Education And Research Detection of group B streptococcus
EP2104512A2 (en) * 2006-12-21 2009-09-30 Emergent Product Development UK Limited Streptococcus proteins, and their use in vaccination
US10114982B2 (en) 2012-05-18 2018-10-30 Tata Consultancy Services Limited Method and system for determining and implementing a viable containment design of a data center
CN106822885B (zh) 2017-02-16 2020-06-30 清华大学 肺炎链球菌疫苗

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328996A (en) 1989-03-29 1994-07-12 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
WO1993014198A1 (en) 1992-01-08 1993-07-22 The Rockefeller University Multifunctional surface protein of streptococci
WO1994021685A1 (en) * 1993-03-19 1994-09-29 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
US6015889A (en) 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
DE69737125T3 (de) 1996-10-31 2015-02-26 Human Genome Sciences, Inc. Streptococcus pneumoniae-Antigene und Impfstoffe
US7196164B2 (en) 1997-07-08 2007-03-27 Human Genome Sciences, Inc. Secreted protein HHTLF25
US7122368B1 (en) * 1997-07-02 2006-10-17 Sanofi Pasteur Limited Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6380370B1 (en) 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
CA2321106C (en) 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
BR9912067A (pt) 1998-07-14 2001-04-10 American Cyanamid Co Composição liofilizada, composição de vacina composta e aquosa composta da composição liofilizada, composição de vacina, método de imunização de um vertebrado através de vacinação, método para a preparação de uma composição liofilizada e de uma suspensão coloidal aquosa
WO2000006736A2 (en) 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
EP1124978A4 (en) 1998-10-30 2003-11-12 Janssen Pharmaceutica Nv UNUSUAL TRANSPOSON FROM YEAR CANDIDA ALBICANS
WO2000025728A2 (en) 1998-11-05 2000-05-11 United States Government As Represented By The Secretary Of The Navy Chromosome 2 sequence of the human malaria parasite plasmodium falciparum and proteins of said chromosome useful in anti-malarial vaccines and diagnostic reagents
DK1141308T3 (da) 1998-12-22 2007-06-04 Microscience Ltd Gruppe B streptococcus proteiner og deres anvendelse
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
CN1733800A (zh) 1998-12-22 2006-02-15 微科学有限公司 外表面蛋白质及其基因和用途
US6605709B1 (en) 1999-04-09 2003-08-12 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics
EP1169343B1 (en) 1999-04-09 2006-05-24 Heska Corporation Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
WO2001034809A2 (en) 1999-11-09 2001-05-17 Glaxo Group Limited Staphylococcus epidermidis nucleic acids and proteins
JP2004507217A (ja) 2000-04-11 2004-03-11 アンスティテュ・パストゥール リステリア菌ゲノム、ポリペプチドおよびその使用
US6974667B2 (en) 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
EP2189473A3 (en) 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nucleic and proteins from streptococcus groups A & B
WO2002077183A2 (en) 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
EP2261241A1 (en) 2001-04-16 2010-12-15 Wyeth Holdings Corporation Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
AU2002367976B2 (en) 2001-06-05 2007-06-21 The Regents Of The University Of Michigan Nanoemulsion vaccines
EP1409013B1 (en) 2001-07-26 2009-11-18 Novartis Vaccines and Diagnostics S.r.l. Vaccines comprising aluminium adjuvants and histidine
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
EP1551357B1 (en) 2002-09-13 2014-07-16 Novartis Vaccines and Diagnostics, Inc. Group b streptococcus vaccine
JP2007535894A (ja) 2003-05-07 2007-12-13 インターツェル・アクチェンゲゼルシャフト ストレプトコッカス・アガラクティエ抗原i+ii
CA2537742C (en) 2003-09-15 2014-07-22 Chiron Corporation Immunogenic compositions for streptococcus agalactiae
CA2582137A1 (en) 2004-10-05 2007-02-15 Wyeth Probe arrays for detecting multiple strains of different species
MX2007007033A (es) 2004-12-22 2007-08-03 Novartis Vaccines & Diagnostic Estreptococus del grupo b.

Also Published As

Publication number Publication date
KR20010089844A (ko) 2001-10-11
JP2002533083A (ja) 2002-10-08
AU1878000A (en) 2000-07-12
NZ512297A (en) 2003-12-19
WO2000037646A3 (en) 2000-10-26
HK1039353A1 (en) 2002-04-19
CA2354135A1 (en) 2000-06-29
HUP0104825A3 (en) 2008-04-28
PL349320A1 (en) 2002-07-15
CY1106559T1 (el) 2012-01-25
PL201887B1 (pl) 2009-05-29
US20080181908A1 (en) 2008-07-31
EA200100700A1 (ru) 2001-12-24
KR20080050550A (ko) 2008-06-09
WO2000037646A2 (en) 2000-06-29
NO20013102D0 (no) 2001-06-21
KR20070101197A (ko) 2007-10-16
CZ20012172A3 (cs) 2001-11-14
US7419672B2 (en) 2008-09-02
CN101066447A (zh) 2007-11-07
OA11734A (en) 2005-05-12
EA004444B1 (ru) 2004-04-29
ATE353367T1 (de) 2007-02-15
US6812021B1 (en) 2004-11-02
KR100790653B1 (ko) 2007-12-31
AU776735B2 (en) 2004-09-23
AP2001002189A0 (en) 2001-06-30
US20090274717A1 (en) 2009-11-05
EP2105504A3 (en) 2010-01-06
SI1141308T1 (sl) 2007-08-31
AP1502A (en) 2005-12-20
PT1141308E (pt) 2007-05-31
EP1141308B1 (en) 2007-02-07
NZ535122A (en) 2006-04-28
HUP0104825A2 (hu) 2002-04-29
EP1757696A2 (en) 2007-02-28
EP1141308A2 (en) 2001-10-10
NZ526879A (en) 2004-12-24
NO20013102L (no) 2001-08-10
ES2281977T3 (es) 2007-10-01
EP1757696A3 (en) 2008-10-29
EP2105504A2 (en) 2009-09-30

Similar Documents

Publication Publication Date Title
DK0835266T3 (da) Modificerede/kimære superantigener og deres anvendelse
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
NO972983L (no) Sulfonamider og deres anvendelse
DK1163271T3 (da) Rekombinant IL-18 antistoffer og deres anvendelse
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
DE69938670D1 (de) Streptococcus antigene
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO20004161D0 (no) Gruppe B streptokokkantigener
NO973338D0 (no) N-(4-aryl-tiazol-2-yl)-sulfonamid-derivater og deres anvendelse
DE69910462D1 (de) Cervicalorthese
NO20003067D0 (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
DK1141308T3 (da) Gruppe B streptococcus proteiner og deres anvendelse
DE59902358D1 (de) Halbbrückenbaugruppe
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO20005502D0 (no) Polymerer og deres anvendelse
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
DE69925271D1 (de) Angiostatin-bindendes protein
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
TR199701666A3 (tr) Sismanliga karsi proteinler
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO991227D0 (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
NO983378D0 (no) Str°mretterutrustning
NO996156L (no) Substituerte cykloheptener, deres fremstilling og anvendelse